Insiders sold 143K and bought nothing on the open market.
All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Mar 2025.
Get an email when INGN's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Jul 1 | Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off | Sold10b5-1 plan | 10,938 | $6.60 | 72K | 68% | Form 4 |
| May 29 | Boyer Jennifer M Yi EVP Entrprs Enblmnt, Ch HR Off | Sold10b5-1 plan | 10,770 | $6.53 | 70K | 40% | Form 4 |
| Mar 3, 2025 | Michael J. Bourque EVP, CFO & Treasurer | Bought | 3,000 | $8.32 | 25K | 6.7% | Form 4 |
| Mar 3, 2025 | Kevin Raymond Merrill Smith CEO and President | Bought | 11,709 | $8.56 | 100K | 20% | Form 4 |
- Jul 110b5-1 planBoyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR Off · sold 10,938 at $6.6072K68% of stake
- May 2910b5-1 planBoyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR Off · sold 10,770 at $6.5370K40% of stake
- Mar 3, 2025Michael J. BourqueEVP, CFO & Treasurer · bought 3,000 at $8.3225K6.7% of stake
- Mar 3, 2025Kevin Raymond Merrill SmithCEO and President · bought 11,709 at $8.56100K20% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Orthopedic, Prosthetic & Surgical Appliances & Supplies · Pick stocks to compare with INGN
Held by ETFs
INGN is in 8 US ETFs. The largest of them, with INGN's weight in each:
iShares Micro-Cap ETFIWC0.04%of the fund
Avantis Total Equity Markets ETFAVTM0.01%of the fund
Federated Hermes MDT Small Cap Core FundFSCC0.12%of the fund
Invesco Russell 2000 Dynamic Multifactor ETFOMFS0.01%of the fund
- CVCultivar ETFCVAR0.40%of the fund
Fidelity Enhanced U.S. All-Cap Equity ETFFEAC0.05%of the fund
Spot a number that looks wrong? Check it in INGN's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing INGN
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.